YCYa. N. Chernov

Ya. N. Chernov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ya. N. Chernov has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Partial nephrectomy for locally advanced renal cell carcinoma in a solitary functioning kidney renal cell carcinoma

    by Ya. N. Chernov, E. N. Shpot, D. V. Chinenov, L. M. Rapoport, D. O. Korolev, V. P. Glybochko, Kh. A. Khizriev, M. D. Trishkin, I. N. Kurepta, E. A. Smirnova, et al.

    BACKGROUND: Locally advanced stage cT3a renal cell carcinoma is characterized by invasion of paranephric cellular tissue, renal sinus or main venous structures and is diagnosed in 20–30 % of cases. While radical nephrectomy remains the “gold standard”, data accumulated in recent years show comparable oncological safety of kidney resection for stage cT3a disease. Patients with solitary kidney remain the most controversial group. AIM: To evaluate immediate, perioperative and early functional results of resection of single-functioning kidney in patients with locally advanced stage cT3a cancer of renal parenchyma. METHODS: The retrospective-prospective study included patients with stage cT3a cancer of renal parenchyma who underwent surgery at the Institute of Human Urology and Reproductive Health of the Sechenov First Moscow State Medical University between January 2014 and October 2025. All patients underwent kidney resection. In total, 20 (2.8 %) of 703 patients had single-functioning kidney. Clinical, anatomical, perioperative, early functional characteristics, as well as frequency of achieving renal trifecta and pentafecta, in these patients and 356 patients who underwent organ-saving treatment and have two kidneys were compared. RESULTS: Patients with solitary kidney had higher creatinine level (104.50 µmol/L versus 90.45 µmol/L; p = 0.0015), lower glomerular filtration rate (56.37 mL/min/1.73 m² versus 71.74 mL/min/1.73 m²; p p = 0.0171). Operative time was shorter in patients with solitary kidney compared to patients with two kidneys (95 min versus 120 min; p = 0.0220). No differences were found in ischemia time, blood loss volume and duration of hospitalization. Negative surgical margin (R0) rate in patients with solitary kidney was lower (55.0 % versus 90.0 %; p = 0.0055). Frequencies of achieving trifecta (63.6 % versus 77.7 %; p = 0.2790) and pentafecta (45.5 % versus 35.7 %; p = 0.5357) did not show significant differences. CONCLUSION: Resection of single-functioning kidney in locally advanced stage cT3a cancer of renal parenchyma is technically feasible and is accompanied by perioperative profile comparable to profile of patients with two kidneys except for higher risk of positive surgical margin. Imperative character of the intervention requires accurate planning of resection volume and personalization of surgical tactics.

  • Open Access

    Overstaging and understaging in cT3a renal cell carcinoma: development and application of an online pT3a prediction calculator

    by Ya. N. Chernov, E. V. Shpot, D. V. Chinenov, L. M. Rapoport, D. O. Korolev, V. P. Glybochko, Kh. A. Khizriev, M. D. Trishkin, I. N. Kurepta, E. A. Smirnova, et al.

    BACKGROUND: Clinical stage cT3a renal cell carcinoma commonly prompts radical nephrectomy, but overdiagnosis of local invasion occurs in 5–10%. Unnecessary nephrectomy causes loss of functional parenchyma and chronic kidney disease risk. Available tools assess anatomical complexity but fail to definitively confirm pT3a, leaving interpretation to the clinician. AIM: To assess the rate and pattern of overstaging of clinical stage cT3a renal cell carcinoma and to demonstrate the clinical application of an online calculator, developed from these data, for predicting the true pathological stage pT3a. METHODS: The study included 703 patients with cT3a stage renal cell carcinoma who underwent surgical treatment between 2014 and 2025. Among 629 patients with histologically verified renal cell carcinoma, groups of pathologically confirmed pT3a ( n = 243) and overstaging cT3a → pT1–2 ( n = 386) were identified; in an extended cohort ( n = 689), 60 additional cases of understaging (cT1–2 → pT3a) were identified. Groups were compared by clinico-anatomical characteristics. Based on a previously developed combined clinico-radiomic model (area under the curve (AUC) = 0.89), a publicly available online calculator for preoperative prediction of pT3a probability was created. RESULTS: The overstaging rate of clinical stage cT3a was 61.4 % (386/629): only 38.6 % of patients had morphologically confirmed pT3a. The overstaging group differed significantly from the confirmed pT3a group in R.E.N.A.L. score (9 vs 10 points; p 3–4 (21.5 % vs 35.9 %; p CONCLUSION: The high rate of overstaging of clinical stage cT3a justifies the need for objective preoperative prediction tools. The developed online calculator provides a practical, real-time application of the clinico-radiomic model directly during preoperative patient counseling.

  • Open Access

    Erectile function evaluation in patients after urethroplasty: systematic review and meta-analysis

    by D. V. Chinenov, E. V. Shpot, H. M. Ismailov, A. V. Proskura, Ya. N. Chernov, L. M. Rapoport, D. O. Korolev, A. N. Gerasimov

    Background . The success of surgical treatment of urethral strictures is often assessed in terms of the quality of urination and the patency of the urethral lumen. Despite the fact that this assessment is carried out according to the above parameters, it seems important to take into account such a possible complication as erectile dysfunction, which can significantly impair the patient’s quality of life. This is the difference in the perception of the success of the surgical intervention by the clinician and the patient. Aim . To determine the relationship between urethroplasty and the likelihood of erectile dysfunction in the postoperative period according to world literature. Materials and methods . The PubMed database was analyzed using the keywords: anterior urethroplasty, posterior urethroplasty, urethroplasty, sexual dysfunction, erectile dysfunction. All articles were reviewed by two independent authors for inclusion based on predetermined criteria. Among the included scientific papers are randomized controlled trials, systematic reviews. Results . Sixteen scientific papers with a total of 1476 patients were included in the final study. The decrease in erectile function after surgery in this meta-analysis is 3 %. The main factors influencing postoperative parameters were age and erectile function at the time of surgery. Conclusion . Most studies state that urethroplasty does not imply a significant impact on erectile function, however, they acknowledge that the occurrence of this complication affects the assessment of treatment outcomes among patients and the further impact on their quality of life, regardless of postoperative urinary function.


  • Open Access

    Comparative analysis of minimally invasive methods of treatment of localized prostate cancer

    by D. V. Chinenov, E. V. Shpot, Ya. N. Chernov, Z. K. Tsukkiev, A. Yu. Votyakov, A. A. Kurbanov, H. M. Ismailov, Yu. V. Lerner, L. M. Rapoport

    The purpose of this work is to study the functional and oncological results of minimally invasive methods in patients with verified prostate cancer. Materials and methods. In our study, 160 patients with identified prostate cancer were presented, treatment was carried out with minimally invasive methods (methods of cryoablation ( n = 53), brachytherapy ( n = 52) and HIFU therapy ( n = 55)). A qualitative assessment of the oncological outcome revealed high levels of prostate-specific antigen (PSA) and the results of repeated transrectal prostate biopsies. The evaluation of functional indicators and quality of life was carried out according to the results of the IIEF-5 (International Index of Erectile Function), IPSS (International Prostate Symptom Score), QoL (Quality of Life), Q max (maximum urination rate of function). Results. The results of oncological control according to the data of positive repeated biopsies were worse in patients after cryoablation (7.54 %), the best indicators of oncological results were observed in patients after brachytherapy. Looking at the IPSS results, it is possible to detect statistical signs of higher scores in the brachytherapy group when various signs are found in the postoperative period, however, these differences do not reach statistical signs in the late period in patients of group brachytherapy and cryoablation. Patients of the cryoablation group showed higher levels of the IIEF-5 in the postoperative period, in the late period of observation of erectile function in patients of the cryoablation group, the statistical data did not differ from those in patients after brachytherapy. Patients after HIFU therapy showed a decrease in de novo erectile dysfunction over a 3-year follow-up period, above average IIEF5 scores, below IPSS scores, and better QoL results. Conclusion. Long-term oncological results are, in general, revisions, however, the recurrence rate is slightly higher in patients after cryoablation. Prostate cancer recurrence was detected in patients of the ISUP 3 group. In patients after HIFU therapy, the quality of urination is higher than in patients of other groups, which can be associated with the laser enucleation of prostate hyperplasia performed by him. The advantage in patients after HIFU therapy was observed in the detection of IIEF-5, thus HIFU therapy had a better effect on the quality of life of patients with pathological prostate cancer.

  • Comparative results of nerve-sparing robotic-assisted prostatectomy

    by E. V. Shpot’, D. V. Chinenov, Ya. N. Chernov, A. Yu. Votyakov, E. N. Gasanov, L. M. Rapoport

    Background . Considering decreasing age of patients with prostate cancer, increasing cancer alertness of first-line doctors as well as increased frequency of radical prostatectomies (RP), the problem of preservation of erectile function (EF) is vitally important (erectile dysfunction develops in 25–75 % of all patients who underwent surgery). The study objective is to analyze preservation of EF after RP depending on the type of endoscopic access and nerve preservation. Materials and methods . Between February of 2015 and February of 2016, in the Urology Clinic of the Sechenov University, 507 RPs were performed; the retrospective single-center study included 231 patients with localized prostate cancer. Surgery was performed with the following accesses: laparoscopic, extraperitoneal laparoscopic, and robotic. Indications for nerve preservation were formulated based on the Briganti nomogram, Partin table as well as patient’s desire to preserve EF. Further evaluation of EF was performed using the International Index of Erectile Function (IIEF5), evaluation of quality of life – using the QoL (Quality of Life) scale. Results . RP with nerve preservation was performed in 150 patients. Surgical time and blood loss did not significantly differ for surgeries with and without nerve preservation (р = 0.064 and р = 0.073 respectively). Pathomorphological examination showed that in all cases (n = 231) integrity of the prostatic capsule and negative surgical margin were achieved. Frequent significant erectile dysfunction and full loss of EF were observed in patients after RP without nerve preservation compared to the group with preserved neurovascular bundles (5.0 (0.0–10.0) points compared to 6.5 (0.8–19.0) points per the IIEF5 scale, р = 0.271): 96.2 % versus 72.2 % (p Conclusions . The best results were achieved in the robotic access group. Surgery with nerve preservation decreased frequency of EF loss. This benefit in conjunction with the radical nature of the operative intervention allows to consider RP techniques with nerve preservation as reasonable approach to erectile dysfunction prevention in patients with localized prostate cancer.


  • Open Access

    First results of active observation of patients with prostate cancer and low oncological risk

    by E. N. Gasanov, D. V. Chinenov, G. N. Akopyan, E. V. Shpot’, M. A. Kodzokov, P. I. Golovnya, A. A. Magomedov, D. K. Karayev, Ya. N. Chernov, L. M. Rapoport

    The study objective is to improve results of treatment of patients with prostate cancer (PC) and low oncological risk. Materials and methods . Since November of 2019 at the Institute of Urology and Human Reproductive Health of the I.M. Sechenov First Moscow State Medical University 40 patients with PC and low oncological risk were included in the protocol of active observation. In all patients, the level of prostate-specific antigen was evaluated every 3 months, digital rectal examination was performed every 6 months, magnetic resonance tomography of the pelvis with intravenous contrast was performed every 12 months. Confirming biopsy of the prostate was performed once, 1 year after the beginning of observation. Every 6 months patients' quality of life was evaluated using the SF-36 (Short Form 36 Health Quality Survey), IIEF-5 (International Index of Erectile Function), IPSS (International Prostate Symptom Score), EPIC-26 (Expanded Prostate Cancer Index Composite) questionnaires. Results. Two (5 %) patients underwent surgical treatment due to PC progression. One (2.5 %) patient preferred treatment due to oncological anxiety. Mean value per the SF-36 questionnaire at the beginning of the study was 63.2 ± 11.5 for psychological component of health and 57.1 ± 9.8 for physical component of health. At the moment, the assessment of the psychological and physical components of health according to SF-36 is 69.5 ± 12.4 and 66.3 ± 8.9 points, respectively. Mean IIEF-5 value at the beginning of the study was 18.8 ± 4.2, currently it is 18.6 ± 3.9. At the beginning of the study mean IPSS value was 9.1 ± 2.1, currently it is 9.4 ± 1.9. For the EPIC-26 questionnaire mean value for all criteria initially was 56.1 ± 5.1, currently it is 68.2 ± 4.6. Conclusion . First results of active observation of patients with PC and low oncological risk demonstrated that this approach allows to avoid unnecessary treatment of patients who do not require immediate intervention and to start treatment on time in cases where it is required while preserving high quality of life for the patients.